Chemoinformaics analysis of 3-Methylbutyl hexanoate
| Molecular Weight | 186.295 | nRot | 7 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 2 |
| Exact Molecular Weight | 186.162 | nRing | 0 |
| Solubility: LogS | -0.754 | nHRing | 0 |
| Solubility: LogP | 1.249 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.6434 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.378 |
| Synth | 2.084 |
| Natural Product Likeliness | 0.321 |
| NR-PPAR-gamma | 0.938 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.213 |
| MDCK | 0.0000481 |
| BBB | 0.998 |
| PPB | 0.155896 |
| VDSS | 0.682 |
| FU | 0.819864 |
| CYP1A2-inh | 0.777 |
| CYP1A2-sub | 0.44 |
| CYP2c19-inh | 0.18 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.309 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.325 |
| CYP3a4-inh | 0.018 |
| CYP3a4-sub | 0.274 |
| CL | 9.464 |
| T12 | 0.808 |
| hERG | 0.004 |
| Ames | 0.054 |
| ROA | 0.889 |
| SkinSen | 0.871 |
| Carcinogencity | 0.735 |
| EI | 0.987 |
| Respiratory | 0.311 |
| NR-Aromatase | 0.187 |
| Antiviral | No |
| Prediction | 0.682841 |